1. Cartagena Protocol: negotiations Pre-1995 Mandate 1996-1999 Biosafety Working Group (BSWG) 1999/2000 ExCOP and informal consultations 2000-2002 Intergovernmental Committee for the Cartegena Protocol February 2004 First meeting of the Parties

2. CBD rules of procedure on participation Meetings open to observers Relatively open process BSWG became more restrictive

3. Roles of industry/NGO observers Lobbying Provision of information Advisory

4. Industry participants E.g. Seed companies/associations; pharmaceutical companies; food manufacturers; technology companies etc Individual companies Industry associations (BIO; Europabio; plant breeders) Global Industry Coalition (from 1998)

5. Industry as: ‘Knowledge holders’ ‘Implementers’

6. Key concerns Scope (esp. commodities) Predictable ‘science-based’ risk assessment process Protect confidential business information Preserve WTO trade rules No liability provisions

7. Key areas for MOP1 Identification and documentation Liability N.B. Capacity-building activities